Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 76
Filter
1.
J Urol ; 185(1): 323-8, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21075390

ABSTRACT

PURPOSE: We evaluated the antilithic effect of Orthosiphon grandiflorus, Hibiscus sabdariffa and Phyllanthus amarus extracts on known risk factors for calcium oxalate stones in rats. MATERIALS AND METHODS: We divided 30 male Wistar rats into 5 equal groups. Controls were fed a standard diet and the remaining groups received a 3% glycolate diet for 4 weeks to induce hyperoxaluria. One glycolate fed group served as the untreated group and the others were given oral extracts of Orthosiphon grandiflorus, Hibiscus sabdariffa or Phyllanthus amarus at a dose of 3.5 mg daily. We collected 24-hour urine and blood samples. Kidneys were harvested for histological examination. We measured the renal tissue content of calcium and oxalate. RESULTS: The Hibiscus sabdariffa group showed significantly decreased serum oxalate and glycolate, and higher oxalate urinary excretion. The Phyllanthus amarus group showed significantly increased urinary citrate vs the untreated group. Histological examination revealed less CaOx crystal deposition in the kidneys of Hibiscus sabdariffa and Phyllanthus amarus treated rats than in untreated rats. Those rats also had significantly lower renal tissue calcium content than untreated rats. All parameters in the Orthosiphon grandiflorus treated group were comparable to those in the untreated group. CONCLUSIONS: Hibiscus sabdariffa and Phyllanthus amarus decreased calcium crystal deposition in the kidneys. The antilithic effect of Hibiscus sabdariffa may be related to decreased oxalate retention in the kidney and more excretion into urine while that of Phyllanthus amarus may depend on increased urinary citrate. In contrast, administering Orthosiphon grandiflorus had no antilithic effect.


Subject(s)
Calcium Oxalate , Hibiscus , Kidney Calculi/prevention & control , Orthosiphon , Phyllanthus , Phytotherapy , Plant Extracts/therapeutic use , Animals , Calcium Oxalate/analysis , Kidney Calculi/chemistry , Male , Rats , Rats, Wistar , Risk Factors
2.
Urol Res ; 37(6): 311-6, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19834703

ABSTRACT

Various studies have suggested that potassium depletion leads to acidosis and hypocitraturia. In Northeastern Thailand, for example, mild hypokalemia and mild hyperoxaluria are observed in most stone formers. However, there are limited reports about the direct link between potassium depletion and the formation of urinary stones, most of which are calcium oxalate stones. Therefore, we studied the direct effect of potassium depletion on the risk factors for calcium oxalate stone formation. Seventy-two rats were fed a control diet or a potassium-deficient diet for 1, 2, or 3 weeks (n = 12 per group). Twenty-four-hour urine collection was done for the measurement of potassium, calcium, oxalate, glycolate, citrate, phosphorus, and magnesium. Lactate dehydrogenase activity was also measured in order to assess renal tubular damage, and kidneys were harvested for histological examination. Furthermore, urinary supersaturation of calcium oxalate was calculated. With potassium depletion, the urinary concentrations of potassium, citrate, magnesium, and phosphorus decreased rapidly. There was no detectable renal damage, renal calcium deposition, and no significant increase of urinary oxalate or calcium. However, the urinary supersaturation index of calcium oxalate increased significantly in rats with potassium depletion. These findings indicate that potassium deficiency may increase the risk of stone formation through enhanced supersaturation.


Subject(s)
Potassium Deficiency/complications , Urinary Calculi/epidemiology , Urolithiasis/epidemiology , Animals , Calcium Oxalate/urine , Citrates/urine , Disease Models, Animal , Hydrogen-Ion Concentration , Magnesium/urine , Male , Potassium/urine , Potassium Deficiency/urine , Rats , Rats, Wistar , Risk Factors , Urinary Calculi/urine , Urolithiasis/urine
3.
Int J Urol ; 15(10): 929-35, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18721203

ABSTRACT

OBJECTIVES: The effect on endogenous oxalate synthesis of acute intravenous loading with ethylene glycol or glycine was investigated in rats on a standard or a vitamin B6-deficient diet. METHODS: Twenty-four male Wistar rats weighing approximately 180 g were randomly divided into ethylene glycol and glycine groups of 12 animals each. These groups were further divided into two subgroups of six animals each that were fed either a standard or a vitamin B6-deficient diet for 3 weeks. Animals of these two subgroups received an intravenous infusion of 20 mg (322.22 micromol) of ethylene glycol or 100 mg (1332.09 micromol) of glycine, respectively. Urine samples were collected just before intravenous infusion of each substance and at hourly intervals until 5 h after receiving the infusion. Urinary oxalate, glycolate, and citrate levels were measured by capillary electrophoresis. RESULTS: Urinary oxalate and glycolate excretion was significantly increased after ethylene glycol administration. Significant differences between the control and vitamin B6-deficient groups were found. In contrast, there were only small changes of oxalate and glycolate excretion after glycine administration. Recovery of the given dose of ethylene glycol as oxalate in 5-h urine was 0.31% and 7.15% in the control and vitamin B6-deficient groups, respectively, whereas recovery of glycolate was 0.68% and 7.22%, respectively. CONCLUSIONS: Ethylene glycol loading has a significant effect on urinary oxalate excretion in both normal and vitamin B6-deficient rats, whereas glycine loading only has a small effect. Oxalate and glycolate excretion after ethylene glycol loading were respectively 23-fold and 11-fold higher in vitamin B6-deficient rats than in controls.


Subject(s)
Diet , Ethylene Glycol/administration & dosage , Glycine/administration & dosage , Oxalates/urine , Vitamin B 6/administration & dosage , Vitamin B Complex/administration & dosage , Animals , Infusions, Intravenous , Male , Rats , Rats, Wistar
4.
Int J Urol ; 15(9): 843-7, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18637159

ABSTRACT

OBJECTIVES: We investigated the time course of changes in bladder activity as well as in spinal and serum levels of glutamate and glycine after partial bladder outlet obstruction (BOO) in rats. METHODS: A total of 36 female rats were divided into six groups: sham operation (control); 3 days, 14 days, and 28 days after BOO; 3 days and 28 days after relief of BOO. Under urethane anesthesia, isovolumetric cystometry was carried out in each group. Then, spinal and serum levels of glutamate and glycine were measured. RESULTS: The interval between bladder contractions was shorter in all of the groups compared with the control group. The amplitude and duration of bladder contractions was decreased at 3 days, 14 days, and 28 days after BOO, and at 3 days after relief of BOO. Spinal and serum glutamate levels showed no changes. However, the spinal glycine level was decreased at 14 days and 28 days after BOO, and at 28 days after relief of BOO. Serum glycine level was also decreased at 28 days after BOO and 28 days after relief of BOO. CONCLUSIONS: Detrusor overactivity during the chronic phase of partial BOO is partly caused by a decrease of glycinergic neuronal activity in the lumbosacral cord. A 3-day period of BOO produces detrusor overactivity, which might be due to an irreversible decrease of spinal glycinergic neuronal activity.


Subject(s)
Glycine/analysis , Spinal Cord/chemistry , Urinary Bladder Neck Obstruction/metabolism , Urinary Bladder Neck Obstruction/physiopathology , Urinary Bladder/physiopathology , Animals , Female , Lumbar Vertebrae , Rats , Rats, Sprague-Dawley , Sacrum
5.
J Urol ; 179(2): 770-4, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18082195

ABSTRACT

PURPOSE: We investigated the mechanisms by which Eviprostat, a phytotherapeutic drug for benign prostatic hyperplasia, influences bladder activity in rats. MATERIALS AND METHODS: A total of 42 female rats were divided into a control group and an Eviprostat group. Rats in the control group were fed a standard diet, while animals in the Eviprostat group were fed a diet containing 0.1% Eviprostat. After 2 weeks 14 rats (7 rats per group) underwent continuous cystometry with physiological saline or 0.1% acetic acid solution and bladder activity was recorded. Body weight, blood pressure, plasma monoamines and adenosine triphosphate were measured in another 14 rats (7 per group). In the remaining 14 rats (7 per group) 0.1% acetic acid solution was infused into the bladder and urinary adenosine triphosphate was measured before and after stimulation. RESULTS: During cystometry with acetic acid the interval between bladder contractions was shorter and maximum bladder contraction pressure was higher in the control group compared with results obtained using physiological saline but such differences were not seen in the Eviprostat group. Plasma adrenaline and noradrenaline were lower in the Eviprostat group than the control group but no difference in blood pressure was observed. Urinary adenosine triphosphate was higher in the 2 groups than before stimulation but the increase was smaller in the Eviprostat group than in the control group. CONCLUSIONS: These results suggest that Eviprostat acts to maintain low catecholamine and also inhibit pathological bladder activity by decreasing adenosine triphosphate release from the bladder.


Subject(s)
Ethamsylate/pharmacology , Phytotherapy , Plant Extracts/pharmacology , Urinary Bladder/drug effects , Adenosine Triphosphate/urine , Animals , Blood Pressure/drug effects , Drug Combinations , Female , Organ Size/drug effects , Rats , Rats, Sprague-Dawley , Urinary Bladder/metabolism , Urinary Bladder/physiopathology
6.
Neurourol Urodyn ; 27(3): 205-11, 2008.
Article in English | MEDLINE | ID: mdl-17661379

ABSTRACT

AIMS: Nocturia is a common symptom in the elderly, and various contributing factors have been suggested. Therefore, in order to investigate which factors are strongly related to occurrence of nocturia, we performed a suite of examinations. METHODS: One hundred eighty volunteers were divided into three groups: a young adult control group (60 healthy persons without nocturia), an elderly control group (60 healthy persons with a low mean frequency of nocturnal urination, i.e., twice per night) in the elderly.


Subject(s)
Biomarkers/metabolism , Body Composition , Circadian Rhythm , Hypertension/complications , Nocturia/etiology , Sleep Wake Disorders/complications , Water-Electrolyte Imbalance/complications , Adult , Age Factors , Aged , Biomarkers/blood , Biomarkers/urine , Blood Pressure , Catecholamines/blood , Female , Humans , Hypertension/metabolism , Hypertension/physiopathology , Male , Melatonin/blood , Natriuretic Peptides/blood , Nocturia/metabolism , Nocturia/physiopathology , Osmotic Pressure , Risk Factors , Sleep Wake Disorders/metabolism , Sleep Wake Disorders/physiopathology , Urination , Urodynamics , Water-Electrolyte Imbalance/metabolism , Water-Electrolyte Imbalance/physiopathology
7.
Biomed Res ; 28(5): 275-80, 2007 Oct.
Article in English | MEDLINE | ID: mdl-18000341

ABSTRACT

We attempted to increase bladder contraction by bone marrow cell transplantation in rats with underactive bladder due to bladder outlet obstruction (BOO). Twelve female rats were anesthetized with halothane to create BOO. After 1 month, the urethral obstruction was removed and they were divided into a transplant group and a sham-operated group (n = 6 each). Bone marrow cells (1 x 10(7) / 0.2 mL) isolated from green fluorescent protein transgenic rats were injected into the bladder wall of the transplant group. Rats from the sham-operated group received injection of culture medium alone. One month after transplantation, isovolumetric cystometry parameters and histological features of bladder were observed as well as intact control rats (n = 6). The amplitude of bladder contractions was larger and the interval between contractions was shorter in the transplant group than the sham-operated group, and there were no differences in these parameters between the transplant group and the control group. Some green fluorescent muscle layers were found in the bladder wall of the transplant group, and these layers were also labeled by anti alpha-smooth muscle actin antibody. These results suggest that transplanted bone marrow cells may improve bladder contractility by differentiating into smooth muscle-like cells.


Subject(s)
Bone Marrow Transplantation , Muscle Contraction/physiology , Urinary Bladder Neck Obstruction/therapy , Urinary Bladder/physiology , Animals , Animals, Genetically Modified , Female , Rats , Rats, Sprague-Dawley , Rats, Wistar
8.
Neurosci Lett ; 429(2-3): 142-6, 2007 Dec 18.
Article in English | MEDLINE | ID: mdl-17997223

ABSTRACT

We examined the effects of propiverine hydrochloride and naftopidil on the urinary ATP level and bladder activity after bladder stimulation in rats. Thirty-nine female rats were divided into a control group, a propiverine group, and a naftopidil group. Rats in the propiverine and naftopidil groups were administered 1 ml/day of propiverine or naftopidil dissolved in water at 5mg/ml, while animals in the control group were administered 1 ml of water only. After 2 weeks, 18 rats (6 per group) underwent continuous cystometry with physiological saline or 0.1% acetic acid solution and their bladder activity was recorded. In the remaining 21 rats (7 per group), 0.1% acetic acid solution was infused into the bladder and the urinary ATP level was measured before and after stimulation (days 0-7). During cystometry with acetic acid in the control group, the interval between bladder contractions was shorter and the maximum bladder contraction pressure was higher than the results for cystometry with physiological saline. The maximum bladder contraction pressure was also increased in the naftopidil group, but such a change was not seen in the propiverine group. The urinary ATP level increased significantly in all three groups after the infusion of acetic acid, but the increase of ATP was smaller in the propiverine group (45% of control) and the naftopidil group (62% of control) than in the control group on day 0. Therefore, the inhibitory effect of propiverine and naftopidil on bladder activity may be partly due to blocking ATP release from the bladder epithelium.


Subject(s)
Adenosine Triphosphate/urine , Benzilates/pharmacology , Naphthalenes/pharmacology , Piperazines/pharmacology , Urinary Bladder, Overactive/drug therapy , Urinary Bladder/drug effects , Acetic Acid/adverse effects , Adrenergic alpha-Antagonists/pharmacology , Animals , Cholinergic Antagonists/pharmacology , Drug Interactions/physiology , Energy Metabolism/drug effects , Energy Metabolism/physiology , Female , Muscle Contraction/drug effects , Muscle Contraction/physiology , Muscle, Smooth/drug effects , Muscle, Smooth/physiology , Pressure , Rats , Rats, Sprague-Dawley , Receptors, Adrenergic, alpha-1/drug effects , Receptors, Adrenergic, alpha-1/metabolism , Receptors, Muscarinic/drug effects , Receptors, Muscarinic/metabolism , Urinary Bladder/metabolism , Urinary Bladder/physiopathology , Urinary Bladder, Overactive/physiopathology , Urinary Bladder, Overactive/urine , Urothelium/drug effects , Urothelium/metabolism
9.
Hinyokika Kiyo ; 53(9): 657-9, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17933145

ABSTRACT

Urethral polyps are rarely found in young girls. A total of 12 urethral polyps have been described in young girls in the English literature to date. Here we present a case of urethral polyp that was detected in the distal urethra of a 12-year-girl. Her chief complaint was a sudden blood discharge. On examination, a 15 x 9 mm polypoid mass with a 7 mm pedicle was seen protruding from the urethral meatus. The mass was excised under general anesthesia. Histopathologically, the polyp was covered with urothelium and squamous epithelium, and was composed of congested blood vessels and inflammatory infiltrates. These findings were similar to those of urethral caruncles in postmenopausal female. She has been free from recurrence and has had no complications, as of 12 months after excision.


Subject(s)
Polyps/pathology , Urethral Diseases/pathology , Child , Female , Humans
10.
Intern Med ; 46(20): 1717-21, 2007.
Article in English | MEDLINE | ID: mdl-17938527

ABSTRACT

123I-Metaiodobenzylguanidine (123I-MIBG)-accumulation in angiomyolipoma (AML) is demonstrated. A 24-year-old Japanese woman presented with tumors in the right retroperitoneal space. The tumors, which accumulated 123I-MIBG, had been thought to be adrenal pheochromocytoma before surgery. They were removed, and were found to be AML. 123I-MIBG was accumulated in AML. 123I-MIBG-accumulation in AML led to a false-positive diagnosis of adrenal pheochromocytoma. Catecholamine levels had been normal. No chromaffin cells were found in the histological examination of the tumors. MIBG accumulation does not necessarily indicate the presence of pheochromocytoma.


Subject(s)
3-Iodobenzylguanidine , Adrenal Gland Neoplasms/diagnostic imaging , Angiomyolipoma/diagnostic imaging , Pheochromocytoma/diagnostic imaging , Radiopharmaceuticals , Adrenal Gland Neoplasms/diagnosis , Adult , Angiomyolipoma/diagnosis , Diagnosis, Differential , False Positive Reactions , Female , Humans , Magnetic Resonance Angiography , Pheochromocytoma/diagnosis , Tomography, Emission-Computed, Single-Photon
11.
Biomed Res ; 28(4): 213-7, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17878601

ABSTRACT

We investigated the factors related to nocturnal urination that was not considered bothersome by comparing various parameters between subjects who felt nocturnal urination as bothersome and those who did not. A total of 94 persons (50 males and 44 females) were enrolled. They urinated >or= once per night. Each subject's perception of nocturnal urination was examined, and the subjects were divided into a bothersome group and a non-bothersome group. Blood biochemical data and urinary condition were compared between the two groups and various subgroups. There were 60 subjects (56 +/- 17 years old) in the non-bothersome group, and 34 subjects (57 +/- 17 years old) in the bothersome group. The serum melatonin level was significantly lower and the total score of the International Prostatic Symptom Score questionnaire (IPSS) and the quality of life (QOL) score were significantly higher in the bothersome group than in the non-bothersome group. Among 50 subjects with nocturnal urination >or= twice per night, the serum melatonin level was also significantly lower and the QOL score was significantly higher in the bothersome group than in the non-bothersome group. In conclusion, nocturnal urination might be not considered bothersome when subjects maintain sufficient levels of melatonin.


Subject(s)
Aging/blood , Melatonin/blood , Urination Disorders/blood , Urination , Adult , Aged , Aged, 80 and over , Aging/pathology , Aging/psychology , Female , Humans , Male , Middle Aged , Prostatitis/blood , Prostatitis/pathology , Prostatitis/psychology , Quality of Life , Surveys and Questionnaires , Urination Disorders/pathology , Urination Disorders/psychology
12.
Clin Exp Nephrol ; 11(2): 147-150, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17593514

ABSTRACT

BACKGROUND: The mean age of starting hemodialysis (HD) in patients with end-stage renal failure is gradually increasing in Japan. It is not uncommon for HD to be commenced in bedridden elderly patients who cannot give informed consent, because of brain damage. However, we have not been able to provide useful advice to their families because there was no relevant information available about the prognosis of bedridden patients on HD. Therefore, we examined the prognosis of bedridden HD patients. METHODS: Two hundred and nineteen patients who received HD were enrolled. These subjects were divided into five groups; (aged <50, 50-59, 60-69, 70-79, and >or=80 years at the commencement of HD), and we compared the overall prognosis between bedridden and nonbedridden patients, as well as that for each age group. RESULTS: There were 76 bedridden patients among the 219 HD patients, and the main cause of their bedridden state before starting HD was cerebrovascular disease. The 50% survival time after the start of HD was 120 months for the nonbedridden patients versus 56 months for bedridden patients. However, the mean (+/-SD) age of the bedridden patients was higher than that of nonbedridden patients (70 +/- 13 versus 64 +/- 14 years). In patients under age 50 years at the start of dialysis, the survival rate was lower in the bedridden than in the nonbedridden patients, but there were no differences between survival rates for bedridden and nonbedridden patients in the other four age groups. CONCLUSIONS: The prognosis of HD patients is poor compared with the general life expectancy of the Japanese population, but whether these patients are bedridden or not has little influence on their survival.


Subject(s)
Bed Rest , Kidney Failure, Chronic/mortality , Kidney Failure, Chronic/therapy , Renal Dialysis , Aged , Aged, 80 and over , Female , Humans , Japan/epidemiology , Kidney Failure, Chronic/ethnology , Life Expectancy/ethnology , Male , Middle Aged , Prognosis , Prospective Studies , Survival Rate
13.
Urol Res ; 35(4): 173-8, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17565492

ABSTRACT

We studied the effects of an intravenous hydroxypyruvate load on endogenous oxalogenesis in rats receiving a standard diet or a vitamin-B6-deficient diet. Twelve male Wistar rats were randomized to two groups and were fed either a standard diet or a vitamin-B6-deficient diet for 3 weeks. Then the animals received an intravenous infusion of 100 mg/ml (960.6 micromol/ml) of hydroxypyruvate slowly over 10 min. Urine samples were collected just before hydroxypyruvate infusion and at hourly intervals until 5 h afterward. Urinary oxalate, glycolate, and citrate levels were measured by capillary electrophoresis. Hourly urinary oxalate excretion peaked within 2 h, while urinary glycolate excretion peaked at 1 h, after the hydroxypyruvate load in both control and vitamin-B6-deficient rats. Both urinary oxalate and glycolate excretion were higher in vitamin-B6-deficient rats than in control rats. Infusion of hydroxypyruvate increased the 5-h urinary oxalate and glycolate excretion to 0.68% (6.56 micromol) and 0.53% (5.10 micromol) of the administered dose (mol/mol), respectively, in the control rats, while oxalate and glycolate excretion, respectively, increased to 2.43% (23.36 micromol) and 0.79% (7.59 micromol) of the dose in the vitamin-B6-deficient rats. Urinary citrate excretion was significantly lower at baseline and all other times in the vitamin-B6-deficient rats than in the control rats. In conclusion, a hydroxypyruvate load increased endogenous oxalate synthesis in control rats, and its synthesis was even greater in vitamin-B6-deficient rats. Vitamin B6 deficiency also resulted in significant hypocitraturia.


Subject(s)
Citric Acid/urine , Glycolates/urine , Oxalates/urine , Pyruvates/metabolism , Vitamin B 6 Deficiency/metabolism , Animals , Male , Random Allocation , Rats , Rats, Wistar , Urolithiasis/metabolism
14.
Biomed Res ; 28(2): 101-5, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17510495

ABSTRACT

We investigated whether nocturia in the elderly was improved by walking exercise, which involved walking rapidly for 30 min or more in the evening or night for 8 weeks. A questionnaire related to micturition and exercise, blood pressure, body composition analysis, blood biochemistry tests, and urinalysis were performed before and after 8 weeks of exercise to investigate the effects of walking. Thirty men (71 years old on average) continued the walking exercise for long enough to undergo evaluation. The number of episodes of nocturia decreased significantly (p < 0.001) from 3.3 +/- 0.7 to 1.9 +/- 0.8 after 8 weeks of walking exercise. The daytime urinary frequency, blood pressure, body weight, body fat ratio, edema ratio, serum catecholamines, triglycerides, and total cholesterol were also decreased. After 8 weeks of exercise, 20 of the subjects (67%) stated that sleep was deeper than before exercise. Assessment of the overall improvement showed that excellent or good results were obtained in 18 patients (60%). The main factor related to the influence of walking exercise on nocturia was that sleep became deeper, which increased the arousal threshold bladder volume. Walking exercise may also have a preventive effect on lifestyle-related diseases.


Subject(s)
Exercise Therapy/methods , Exercise , Nocturia/therapy , Sleep , Walking , Aged , Blood Pressure , Body Composition , Humans , Life Style , Male , Surveys and Questionnaires , Time Factors
15.
Int J Urol ; 14(5): 470-2, 2007 May.
Article in English | MEDLINE | ID: mdl-17511740

ABSTRACT

Physicians recommend a high water intake to prevent cerebral infarction by decreasing blood viscosity. However, there is no evidence that high water intake decreases viscosity, although it increases urinary frequency. Therefore, we investigated the change of blood viscosity and urinary frequency by high water intake. We examined the change of blood viscosity after acute water intake, the circadian rhythm of blood viscosity, and the change of early morning blood viscosity and urinary frequency after high water intake for 1 week in healthy volunteers aged 31-75 years. Blood viscosity decreased transiently by acute water intake, but remained within the range of its circadian rhythm. Morning blood viscosity did not alter by high water intake for 1 week, although urinary frequency increased. Because excessive water intake increases urinary frequency without decreasing blood viscosity, a high water intake should not be recommended in persons with urinary frequency.


Subject(s)
Blood Viscosity , Drinking , Urination , Adult , Aged , Female , Humans , Male , Middle Aged
16.
Prostate ; 67(9): 999-1009, 2007 Jun 15.
Article in English | MEDLINE | ID: mdl-17440967

ABSTRACT

BACKGROUND: In men, prostate cancer frequently metastasizes to the bones, where it forms osteoblastic lesions with an osteolytic element that cause pain. However, the role of osteoclastogenesis in bone metastasis of human prostate cancer is unknown. Bisphosphonates are already known to be beneficical for treating osteolytic bone metastases, so we employed a model of osteoblastic bone tumor of human prostate cancer to investigate whether a new bisphosphonate (YM529: minodronate) could inhibit both the formation of bone tumors and the progression of established osteoblastic tumors. METHODS: Human prostate cancer cells (LNCaP) were injected into adult human bone implants in nonobese diabetic/severe combined immunodeficient mice, after which osteoblastic bone tumors developed. YM529 (1 microg/day) was administered subcutaneously every day for 2 weeks, starting either immediately or 2 weeks after implantation of the tumor cells, and the mice were sacrificed at 4 weeks after implantation. The bone tumors were examined histologically and the number of tartrate-resistant acid phosphatase-stained osteoclasts in each tumor focus was counted. RESULTS: Histomorphometric analysis revealed that YM529 markedly inhibited both the formation of bone tumors and the progression of established tumors, as well as markedly reducing the number of osteoclasts. CONCLUSIONS: YM529 reduced the tumor burden in bone by inhibiting both the formation of new lesions and the progression of existing tumors, suggesting that osteoclasts are involved in the formation of bone tumors by prostate cancer. Treatment with this bisphosphonate may potentially be beneficial for patients with bone metastases of prostate cancer.


Subject(s)
Bone Neoplasms/prevention & control , Bone Neoplasms/secondary , Diphosphonates/pharmacology , Imidazoles/pharmacology , Osteoblasts/pathology , Prostatic Neoplasms/pathology , Animals , Humans , Male , Mice , Mice, Nude , Neoplasm Transplantation/pathology , Osteoblasts/drug effects , Transplantation, Heterologous
17.
Urology ; 69(2): 275-9, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17320663

ABSTRACT

OBJECTIVES: Frequent recurrence of superficial bladder cancer is a major problem that impairs patients' quality of life. We studied the current treatment of superficial bladder cancer, including the economic aspects of intravesical instillation. METHODS: A total of 138 superficial bladder cancers were assessed. The tumor characteristics and treatments were investigated during a mean observation period of 86 months by univariate and multivariate analyses. The costs associated with intravesical instillation of bacille Calmette-Guérin (BCG) and its side effects were subjected to cost-effectiveness analysis. RESULTS: Tumor histologic examination revealed grade 1 in 21 lesions, grade 2 in 60 lesions, grade 3 in 40 lesions, and unclassified in 17 lesions. The pathologic stage was Stage Ta in 85 lesions, T1 in 47 lesions, and Tis in 6 lesions. Univariate and multivariate analyses showed that intravesical instillation of BCG was the most significant factor preventing recurrence, and intravesical chemotherapy had no impact on recurrence. The 5-year recurrence-free survival rate was 78% and 28% for tumors with and without BCG instillation, respectively. The cost-effectiveness ratio of BCG instillation was approximately 3900 dollars/5-yr recurrence-free period. CONCLUSIONS: Our results have indicated that BCG is an effective adjuvant therapy after transurethral resection of superficial bladder cancer in the current medical environment.


Subject(s)
BCG Vaccine/administration & dosage , BCG Vaccine/economics , Carcinoma, Transitional Cell/drug therapy , Cost of Illness , Neoplasm Recurrence, Local/prevention & control , Urinary Bladder Neoplasms/drug therapy , Administration, Intravesical , Adult , Aged , Aged, 80 and over , Analysis of Variance , Carcinoma, Transitional Cell/mortality , Carcinoma, Transitional Cell/pathology , Carcinoma, Transitional Cell/surgery , Chemotherapy, Adjuvant , Cohort Studies , Cost-Benefit Analysis , Cystectomy/methods , Female , Humans , Immunohistochemistry , Male , Middle Aged , Multivariate Analysis , Neoplasm Staging , Probability , Prognosis , Retrospective Studies , Survival Analysis , Treatment Outcome , Urinary Bladder Neoplasms/mortality , Urinary Bladder Neoplasms/pathology , Urinary Bladder Neoplasms/surgery
18.
Int J Urol ; 14(1): 33-8, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17199857

ABSTRACT

OBJECTIVE: We examined whether the existence of spina bifida occulta or ultrasonographic bladder abnormalities was related to the outcome of treatment for primary nocturnal enuresis in children. METHODS: Between April 1996 and September 2005, a total of 77 subjects (53 boys and 24 girls, aged 5-18 years; mean age, 9.9 years) with primary nocturnal enuresis were studied. Plain X-ray films of the spine and ultrasonographic bladder measurements (bladder wall thickness, bladder neck descent and bladder neck opening) were obtained and the correlations with the outcome of treatment using imipramine hydrochloride were assessed. RESULTS: On plain X-ray films of the spine, spina bifida occulta (lumbar vertebrae in three, lumbosacral vertebrae in 19 and sacral vertebrae in 31) was recognized in 53 children (69%). Ultrasonographic bladder abnormalities were recognized in 40 children (52%). Children with lumbar and lumbosacral spina bifida occulta showed a higher rate of concomitant ultrasonographic bladder abnormalities (P = 0.006) and had a poorer response to treatment (P = 0.041) compared with the children who had sacral spina bifida occulta. Children with ultrasonographic bladder abnormalities had a worse response to treatment (P = 0.005) compared to the children without bladder abnormalities. CONCLUSIONS: The presence of lumbar spina bifida occulta and ultrasonographic bladder abnormalities was related to the outcome of treatment for primary nocturnal enuresis in children, suggesting that spinal radiography and vesical ultrasonography may be useful predictive tests.


Subject(s)
Imipramine/therapeutic use , Nocturnal Enuresis/drug therapy , Nocturnal Enuresis/etiology , Spina Bifida Occulta/complications , Urinary Bladder/abnormalities , Urinary Bladder/diagnostic imaging , Adolescent , Child , Child, Preschool , Female , Humans , Male , Risk Factors , Treatment Outcome , Ultrasonography
19.
J Urol ; 177(2): 762-5, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17222677

ABSTRACT

PURPOSE: We investigated the effect of the blended herbal medicine Gosha-jinki-gan on bladder activity and the autonomic nervous system in rats. MATERIALS AND METHODS: A total of 42 female rats were divided into a control diet group of 21 and a Gosha-jinki-gan diet group of 21. Rats in the control diet group were fed a standard diet, while animals in the Gosha-jinki-gan were fed a special diet containing 1.08% Gosha-jinki-gan (TJ107, Tsumura Co., Tokyo, Japan). After 4 weeks 28 rats, including 14 in the control and 14 in the Gosha-jinki-gan group, underwent continuous cystometry with physiological saline or 0.1% acetic acid solution and bladder activity was recorded. The remaining 14 rats were anesthetized with halothane, and body weight, serum amino acid (glutamate and glycine) and plasma monoamine (noradrenaline, adrenaline, dopamine and serotonin) levels were measured. RESULTS: The amplitude of bladder contraction on continuous cystometry with physiological saline was lower in the Gosha-jinki-gan diet group than in the control diet group, and plasma dopamine and serotonin levels were also lower in the Gosha-jinki-gan group. When cystometry was done with 0.1% acetic acid, the interval between bladder contractions was shortened in the control and Gosha-jinki-gan groups. However, the interval and duration of bladder contractions were longer in the Gosha-jinki-gan than in the control group. CONCLUSIONS: These results suggest that Gosha-jinki-gan inhibits bladder activity by maintaining the balance of the sympathetic and parasympathetic nervous systems at a low level.


Subject(s)
Autonomic Nervous System/drug effects , Autonomic Nervous System/physiology , Drugs, Chinese Herbal/pharmacology , Urinary Bladder/drug effects , Urinary Bladder/physiology , Animals , Female , Rats , Rats, Sprague-Dawley
20.
Biomed Res ; 28(6): 287-94, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18202518

ABSTRACT

We compared the serum cholinesterase (ChE) level and various parameters between patients with or without overactive bladder (OAB) and/or neurogenic bladder (NB). A total of 258 patients who met the following criteria were enrolled: the presence/absence of OAB and/or NB was documented, laboratory data were available, and liver and renal functions were normal. Patients were divided into the 3 groups: 1) a NB+/OAB+ group who had both NB and OAB, 2) a NB-/OAB+ group who had OAB alone, and 3) an OAB- group who did not have OAB. The relationship between the presence of OAB and various biochemical parameters were examined, as well as the therapeutic outcome in relation to the same biochemical parameters. Forty-three patients had both NB and OAB (NB+/OAB+), 66 patients had OAB without NB (NB-/OAB+), and 149 patients had no OAB (OAB-). Serum ChE, total protein, and albumin levels were lower in the NB-/OAB+ group than the NB+/OAB+ group or the OAB- group. In the NB-/OAB+ group, a higher serum albumin or ChE level was associated with a better therapeutic outcome. These results suggest that a decrease of serum ChE level is related to the occurrence of OAB and the poor response to treatment in OAB patients without NB.


Subject(s)
Cholinesterases/blood , Urinary Bladder, Neurogenic/metabolism , Urinary Bladder, Overactive/metabolism , Urinary Bladder/physiopathology , Female , Humans , Male , Serum Albumin/metabolism , Urinary Bladder, Neurogenic/physiopathology , Urinary Bladder, Overactive/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...